FDA
Senaste nytt om FDA - Nyheter, podcasts, videor och inlägg på sociala medier om FDA.
Senaste nytt om FDA - Nyheter, podcasts, videor och inlägg på sociala medier om FDA.
Q-linea har beslutat att genomföra en företrädesemission om cirka 225 miljoner kronor, bland annat med syftet att stödja kommersiella aktiviteter på nyckelmarknader med tonvikt på den amerikanska marknaden efter FDA-godkännande.
Bioarctics partner Eisai har slutfört sin stegvisa ansökan till amerikanska läkemedelsverket FDA om marknadsgodkännande (Biologics License Application) av lecanemab för veckovis subkutan underhållsbehandling med en autoinjektor. Det framgår av ett pressmeddelande.
Paragonix Technologies, ett företag inom produkter och tjänster för organtransport som nyligen förvärvats av medicinteknikbolaget Getinge, har fått FDA-godkännande för Kidney Vault, en produkt för optimerad transport och hantering av donerade njurar vid transplantation. Det framgår av ett pressmeddelande.
En efter en har restaurangbesökare blivit sjuka efter att ha ätit på McDonalds. De flesta av de som blivit sjuka har ätit på McDonalds i Colorado och Nebraska, men totalt handlar det om tio delstater i USA. Minst 49 har rapporterats sjuka av E-coli-bakterier efter att ha ätit på restaurangen, uppger amerikanska hälsomyndigheter. Minst tio har behövt sjukhusvård. I Colorado har en av de som insjuknat, en äldre person, dött efter att ha blivit smittad. Ätit samma hamburgare De som blivit sjuka har alla uppgett att de ätit på McDonalds en kort tid innan de blev sjuka, och de flesta nämnde specifikt hamburgaren "Quarter pounder". Nu tar restaurangkedjan bort hamburgaren från menyn i flera delstater, tillfälligt. – Vi tar livsmedelssäkerheten på största allvar, det är det rätta att göra, uppger McDonalds i ett uttalande. Mycket pekar på att den skivade lök som serveras på hamburgarna är en trolig källa till kontamineringen, enligt en preliminär undersökning gjord av USA:s läkemedelsmyndighet FDA. Samtidigt undersöker USA:s jordbruksdepartement själva biffarna. Fått allvarliga njurkomplikationer E-coli är en grupp bakterier som finns i tarmarna. Ett barn som insjuknat har fått allvarliga njurkomplikationer. – Åtminstone i kött, när man slaktar ett djur, kan man ha kontaminering från de bakterier som finns i tarmarna. E-coli finns i tarmarna. Men också människor som kanske inte har tvättat händerna ordentligt. Det finns hur många sätt du kan få den typen av kontaminering, säger läkaren Celine Gounder i CBS News.
Camurus meddelar att den amerikanska läkemedelsmyndigheten (FDA) utfärdat en begäran om ytterligare information, Complete Response Letter (CRL), avseende Camurus ansökan om marknadsgodkännande för CAM2029 (oktroetid) månadsdepå för behandling av patienter med akromegali. Det framgår av ett pressmeddelande.
Biosimilarutvecklaren Xbrane Biopharma har haft ett vetenskapligt rådgivande möte med den amerikanska läkemedelsmyndigheten FDA kring utvecklingen av biosimilarkandidaten Xdivane. Det framgår av ett pressmeddelande.
Xspray Pharma har haft möte med den amerikanska läkemedelsmyndigheten FDA och planerar att lämna in begärda kompletteringar till sin ansökan om marknadsgodkännande (NDA) för Dasynoc under fjärde kvartalet 2024. Det framgår av ett pressmeddelande.
Läkemedelsbolaget Diamyd Medical, som utvecklar banbrytande behandlingar för typ 1-diabetes, har levererat en rad tunga nyheter på kort tid. Nyligen presenterades mycket positiva resultat från en viktig interimsanalys. Dessutom har bolagets läkemedel fått snabbspårstatus ”Fast Track designation” av den amerikanska läkemedelsmyndigheten FDA, vilket kan påskynda marknadslanseringen. Typ 1-diabetes är en allvarlig autoimmun sjukdom som miljontals […]
Xspray Pharma slaktades på börsen efter att FDA krävt mer information från bolaget. Vd Per Andersson tror fortfarande fullt ut på bolaget, men är djupt kritisk till den amerikanska myndighetens agerande. ”Det är oerhört frustrerande”, säger han.
Forskningsbolaget Xspray Pharma rasar efter ett amerikanskt myndighetsbesked i fredags kväll som Pareto tror kommer leda till stora nedrevideringar i estimaten. Även storägaren Flerie dras med i fallet.
This course aims to prepare clinical investigators to conduct high-quality research, and to acquire a practical understanding of ...
The Food and Drug Administration may finally move to ban artificial red food dye, which is found in beverages, snacks, cereals ...
The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency ...
During a Senate Health, Education, Labor & Pensions Committee hearing on Thursday, Sen. Bernie Sanders (I-VT) questioned ...
Do you know how many of the products you use every day are regulated by the #FDA? About 20 cents of every dollar you spend ...
In 1999, an FDA food investigator found traces of mercury in America’s favorite sweetener. But when she presented her findings, she was told to stop her research. The incident rang alarm bells — was the FDA covering up threats to public health? More recently, the agency’s sources of funding and their role in the Opioid Crisis have drawn suspicion and criticism. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Millions of customers have explored their genome with 23andMe. But when the company started in 2006, the idea of consumer DNA testing was heresy to the medical establishment. The FDA once even ordered 23andMe to stop selling its health testing product. The company persevered to make allies out of adversaries, and became the only FDA-approved product on the market. Learn how 23andMe defined the DNA testing category, and used its success to enter the massive new field of drug discovery. Host: Roelof Botha, Sequoia Capital Featuring: Anne Wojcicki, Richard Scheller Transcript: https://www.sequoiacap.com/podcast/crucible-moments-23andMe/ Learn more about your ad choices. Visit podcastchoices.com/adchoices
The FDA drug approval process is known to be a lengthy and rigorous one. But the FDA-approved ingredient phenylephrine — found in common cold medicines like Sudafed, Mucinex, and NyQuil — was recently found to be no better than a placebo. Phenylephrine has been on store shelves for nearly 90 years. How could that happen?In this episode of Tiny Matters, Sam and Deboki are joined by none other than Deboki's dad, Deb Chakravarti. Deb is a professor with years of industry experience and the current director of the York College FDA Partnership. He helps dissect the FDA's recent findings and how its history and ever-evolving role in the pharmaceutical industry contributed to phenylephrine being used in oral cold medicines for so long.Deb, Deboki and Sam also unpack pharmaceutical ethics cases, like thalidomide in the 1950s and 60s, and the case of Vioxx in the early 2000s, which led to tens of thousands of deaths. Sam and Deboki cap off the episode with tiny show and tells about how the nose is really 2 noses (!) and the story of a new, ingestible, vitamin-sized capsule that could protect people from dying of an opioid overdose, sleep apnea, or other conditions that depress breathing.Check out PNAS Science Sessions here and wherever you listen to podcasts. Links to the Tiny Show & Tell stories are here and here. Pick up a Tiny Matters mug here! All Tiny Matters transcripts are available here.
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers. Read this story here. Learn more about your ad choices. Visit megaphone.fm/adchoices
Daniel Fabricant, Ph.D served as the Director of the Division of Dietary Supplement Programs at the U.S. Food and Drug Administration (FDA), where he directed agency policy, public affairs and regulatory action regarding regulation of the dietary supplement industry for more than three years. Today Dr. Fabricant is CEO and President of the Natural Products Association (NPA), the nation’s largest and oldest trade organization representing the natural products industry, including dietary supplements, foods, personal care products and more. EPISODE LINKS https://www.npanational.org https://twitter.com/drfabricant FOLLOW DANNY JONES https://www.instagram.com/jonesdanny https://twitter.com/jonesdanny JOIN OUR KULT: https://bit.ly/koncretepatreon OUTLINE 0:00 - Introduction 2:30 - Healthcare in the US 7:55 - How the FDA works 14:33 - Patents / Branded drugs 24:00 - Daniels role at FDA 33:29 - NAC 36:27 - NMN 41:42 - FDA tried to make fish oil a prescription drug 43:24 - Is David Sinclair trying to monopolize NMN? 51:04 - Peptides 1:02:56 - Cannabis & CBD 1:14:32 - Testosterone therapy for men 1:18:50 - FDA pandemic response 1:31:07 - Creatine 1:34:10 - Cancer vaccines 1:40:33 - Universal health care
Major averages notched their third straight positive session. Wells Fargo’s Scott Wren and CFRA’s Sam Stovall break down the market action. Jefferies analyst Brent Thill breaks down Oracle’s revenue miss. Caruso Founder Rick Caruso talks rumors of a Macy’s sale and the broader state of commercial real estate. CRISPR Therapeutics CEO Sam Kulkarni on his company’s partnership with Vertex Pharma leading to breakthrough FDA approval for a sickle cell treatment, the first in US to be approved that uses CRISPR gene-editing technology.
In this episode, Joe interviews Mason Marks, MD, JD: drug policy analyst, writer, Professor at the Florida State University College of Law, and senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. As somewhat of an expert on drug policy and FDA regulation, Marks discusses much of the current legal landscape: What was controversial and most interesting about the FDA’s recent guidance for researchers running clinical trials; how an amendment changed Colorado’s Natural Medicine Act and the odd vibe coming from the rule-making process (very private with canceled meetings and a notable lack of urgency); concerns over Oregon’s confusing program not being sustainable; and how Senate Bill 303 drastically changed confidentiality and how personal data would be collected in the state. He also discusses the complications and ethics of end-of-life care and psychedelics; the theoretical heart valve risk from chronic use and ways we could research this; the challenge of informed consent; the legal risk of transactions involving people gifting illegal substances; the Gracias Foundation’s recent $16 million grant to Harvard and how people at Harvard feel about psychedelics; and more. POPLAR, which was founded to essentially change laws around psychedelics, is hosting a conference on February 16 in Manhattan called “Drug Law for the 21st Century,” which will be looking back on 50 years of DEA drug policy and envisioning what could be different going forward. Click here to head to the show notes page.
“Abolish the FDA” has become a popular slogan in libertarian circles. I’m sympathetic to the spirit of the demand. But a slogan isn’t a plan, and this one is even less of a plan than usual. I used to think that since libertarians always lose, there was no point in having a real plan for what to do if they won. But now that they’ve gone from “literally always lose” to “only lose 99.9% of the time” . . . https://www.astralcodexten.com/p/beyond-abolish-the-fda
If you’ve listened to some of the dialogue in hearings on Capitol Hill about how to regulate AI, you’ve heard various folks suggest the need for a regulatory agency to govern, in particular, general purpose AI systems that can be deployed across a wide range of applications. One existing agency is often mentioned as a potential model: the Food and Drug Administration (FDA). But how would applying the FDA work in practice? Where does the model break down when it comes to AI and related technologies, which are different in many ways from the types of things the FDA looks at day to day? To answer these questions, Justin Hendrix spoke to Merlin Stein and Connor Dunlop, the authors of a new report published by the Ada Lovelace Institute titled Safe before sale: Learnings from the FDA’s model of life sciences oversight for foundation models.
FDA-approved Casgevy & Lyfgenia made from patients’ blood stem cells which are modified and given back as single-dose infusion. India ‘in preclinical stage’ of trial of similar therapy.----more----https://theprint.in/health/genetic-scissors-india-using-same-tech-to-find-sickle-cell-cure-as-gene-therapy-approved-by-us-fda/1884468/
Show Notes: (Bonus) FDA Approves Mass Extermination Inoculation Revisited, 2024 Cancer Rates are Sky High!! Raw Discussion may be disturbing for some. The Information from 2021 is now very relevant in 2024 now that all of the formerly withheld and censored statistics have now been revealed!!!! {For those who wish to support the show with donations, please send them to :$aigner2019(cashapp) or https://www.paypal.me/Aigner2019 or Zelle(1-617-821-3168).}
Now that the pharmaceutical industry has made its hundreds of billions from vaccines, and despite an all out smear campaign the agency itself participated in, the Food & Drug Administration has approved the drug Ivermectin as a treatment for COVID. So it turns out that, according to the FDA, it’s OK even if you’re not a horse for you to take Ivermectin to treat your COVID. That’s what you call a win-whinny. Guest host Craig “Pasta” Jardula, along with Jimmy Dore and Americans’ Comedian Kurt Metzger discuss why Ivermectin had to be so severely demonized during the early days of the pandemic but now can be approved in such a cavalier fashion. Plus a segment on all the terrible jokes late night night comedians made about taking Ivermectin, which has now been approved by the FDA to treat COVID. Also featuring Stef Zamorano and Mike MacRae! And a phone call from Alec Baldwin!